| Chimeric antigen receptor T cells for sustained remissions in leukemia SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ... New England Journal of Medicine 371 (16), 1507-1517, 2014 | 5670 | 2014 |
| The who's who of T‐cell differentiation: human memory T‐cell subsets YD Mahnke, TM Brodie, F Sallusto, M Roederer, E Lugli European journal of immunology 43 (11), 2797-2809, 2013 | 1035 | 2013 |
| Chimeric antigen receptor T cells against CD19 for multiple myeloma AL Garfall, MV Maus, WT Hwang, SF Lacey, YD Mahnke, JJ Melenhorst, ... New England Journal of Medicine 373 (11), 1040-1047, 2015 | 633 | 2015 |
| Bone marrow as a priming site for T-cell responses to blood-borne antigen M Feuerer, P Beckhove, N Garbi, Y Mahnke, A Limmer, M Hommel, ... Nature medicine 9 (9), 1151-1157, 2003 | 391 | 2003 |
| The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis M Roederer, L Quaye, M Mangino, MH Beddall, Y Mahnke, ... Cell 161 (2), 387-403, 2015 | 319 | 2015 |
| Optimizing a multicolor immunophenotyping assay YD Mahnke, M Roederer Clinics in laboratory medicine 27 (3), 469-485, 2007 | 251 | 2007 |
| Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome LRV Antonelli, Y Mahnke, JN Hodge, BO Porter, DL Barber, ... Blood, The Journal of the American Society of Hematology 116 (19), 3818-3827, 2010 | 210 | 2010 |
| Quantifying spillover spreading for comparing instrument performance and aiding in multicolor panel design R Nguyen, S Perfetto, YD Mahnke, P Chattopadhyay, M Roederer Cytometry Part A 83 (3), 306-315, 2013 | 132 | 2013 |
| Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome YD Mahnke, JH Greenwald, R DerSimonian, G Roby, LRV Antonelli, ... Blood, The Journal of the American Society of Hematology 119 (13), 3105-3112, 2012 | 110 | 2012 |
| Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells YD Mahnke, J Schwendemann, P Beckhove, V Schirrmacher Immunology 115 (3), 325-336, 2005 | 96 | 2005 |
| OMIP-017: human CD4 (+) helper T-cell subsets including follicular helper cells YD Mahnke, MH Beddall, M Roederer Cytometry A 83 (5), 439-440, 2013 | 69 | 2013 |
| Publication of optimized multicolor immunofluorescence panels Y Mahnke, P Chattopadhyay, M Roederer Cytometry Part A 77 (9), 814-818, 2010 | 67 | 2010 |
| Randomized, phase ii dose optimization study of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed, refractory CLL DL Porter, NV Frey, JJ Melenhorst, WT Hwang, SF Lacey, P Shaw, ... Blood 124 (21), 1982, 2014 | 62 | 2014 |
| Bone marrow microenvironment facilitating dendritic cell: CD4 T cell interactions and maintenance of CD4 memory M Feuerer, P Beckhove, Y Mahnke, M Hommel, B Kyewski, A Hamann, ... International journal of oncology 25 (4), 867-876, 2004 | 61 | 2004 |
| LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry E Devêvre, P Romero, YD Mahnke Journal of immunological methods 311 (1-2), 31-46, 2006 | 37 | 2006 |
| OMIP‐001: Quality and phenotype of Ag‐responsive human T‐cells YD Mahnke, M Roederer Cytometry Part A 77 (9), 819-820, 2010 | 36 | 2010 |
| OMIP-015: human regulatory and activated T-cells without intracellular staining YD Mahnke, MH Beddall, M Roederer Cytometry a 83 (2), 179-181, 2013 | 32 | 2013 |
| In vivo persistence of codominant human CD8+ T cell clonotypes is not limited by replicative senescence or functional alteration L Derré, M Bruyninx, P Baumgaertner, E Devevre, P Corthesy, C Touvrey, ... The Journal of Immunology 179 (4), 2368-2379, 2007 | 31 | 2007 |
| SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery S Hu-Lieskovan, S Bhaumik, K Dhodapkar, JCJB Grivel, S Gupta, ... Journal for immunotherapy of cancer 8 (2), 2020 | 27 | 2020 |
| Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+ lymphomas SJ Schuster, J Svoboda, SD Nasta, DL Porter, EA Chong, Y Mahnke, ... Blood 124 (21), 3087, 2014 | 26 | 2014 |
